With just 5 years remaining to achieve the goal of ending TB by 2030, we need to utilize better tools to combat drug-resistant TB (DR-TB). This animation highlights how Next-Generation Sequencing (NGS) plays a crucial role in speeding up progress. Discover how NGS provides faster, more comprehensive actionable data, to help impact health outcomes. Learn more: https://sapac.illumina.com/destination/tuberculosis-surveillance.html?utm_medium=social&catt=organic_social_YouTube #NGS #Tuberculosis #DRTB #DrugResistance #WHO #EndTB Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc